HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

A comparison of the VHI, VHI-10, and V-RQOL for measuring the effect of botox therapy in adductor spasmodic dysphonia.

AbstractBACKGROUND:
Although disease-specific quality-of-life (QOL) instruments are an invaluable outcome measure in spasmodic dysphonia, there is no consensus on which QOL instrument should be used.
OBJECTIVE:
To determine the responsiveness of the Voice Handicap Index (VHI), Voice Handicap Index-10 (VHI-10), and Voice-Related Quality of Life (V-RQOL) to the treatment effect of botulinum toxin (Botox) in adductor spasmodic dysphonia (ADSD).
SETTING:
Stanford University Voice and Swallowing Center.
DESIGN:
Prospective case series (level of evidence=4).
METHODS:
Consecutive ADSD patients with a stable Botox dose-response relationship were recruited prospectively. VHI, VHI-10, and V-RQOL scores were obtained pretreatment and during the middle third of the posttreatment injection cycle.
RESULTS:
Thrity-seven patients completed the follow-up. The average total Botox dose was 0.88 units. The average follow-up time after injection was 7.84 weeks. The pretreatment QOL scores reflected the burden of the disease. All the three instruments were highly correlated in subscale and total scores. After treatment, all three instruments showed significant improvement.
CONCLUSION:
The VHI, VHI-10, and V-RQOL all reflected the morbidity associated with ADSD and were significantly responsive to the effect of Botox therapy. The choice of instrument should be based on physician preference.
AuthorsSanjay Morzaria, Edward J Damrose
JournalJournal of voice : official journal of the Voice Foundation (J Voice) Vol. 26 Issue 3 Pg. 378-80 (May 2012) ISSN: 1873-4588 [Electronic] United States
PMID20951552 (Publication Type: Comparative Study, Journal Article)
CopyrightCopyright © 2012 The Voice Foundation. Published by Mosby, Inc. All rights reserved.
Chemical References
  • Neuromuscular Agents
  • Botulinum Toxins, Type A
Topics
  • Adult
  • Aged
  • Botulinum Toxins, Type A (administration & dosage)
  • Cost of Illness
  • Disability Evaluation
  • Dose-Response Relationship, Drug
  • Dysphonia (diagnosis, drug therapy, physiopathology, psychology)
  • Dystonic Disorders (diagnosis, drug therapy, physiopathology, psychology)
  • Female
  • Humans
  • Injections
  • Laryngeal Muscles (drug effects, physiopathology)
  • Male
  • Middle Aged
  • Neuromuscular Agents (administration & dosage)
  • Predictive Value of Tests
  • Prospective Studies
  • Quality of Life
  • Surveys and Questionnaires
  • Time Factors
  • Treatment Outcome
  • Voice Quality (drug effects)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: